Comment from Arnold Ventures

Summary: Arnold Ventures, a philanthropy, supports the FDA's efforts to address generic drug repurposing and proposes specific policy changes to overcome market and regulatory barriers. They recommend creating a drug repurposing support program, allowing non-manufacturers to submit evidence via Citizen Petitions, and establishing a "labeling only" 505b2 pathway with liability protections.